breast carcinoma (Cancer)
Information
- Disease name
- breast carcinoma
- Disease ID
- DOID:3459
- Description
- "A breast cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells." [url:http\://en.wikipedia.org/wiki/Breast_cancer]
Disease area statistics
Chromosome band
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02194387 | Active, not recruiting | N/A | Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members | September 17, 2014 | September 30, 2025 |
| NCT02632045 | Active, not recruiting | Phase 2 | Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer | March 2016 | June 10, 2024 |
| NCT02204098 | Active, not recruiting | Phase 1 | Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy | January 7, 2015 | August 31, 2028 |
| NCT00892814 | Active, not recruiting | N/A | Partial Breast Versus Whole Breast Irradiation in Elderly Women Operated on for Early Breast Cancer | May 14, 2009 | March 2026 |
| NCT03542695 | Active, not recruiting | Early Phase 1 | 64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy | November 3, 2021 | February 20, 2025 |
| NCT02750826 | Active, not recruiting | Phase 3 | Breast Cancer WEight Loss Study (BWEL Study) | August 2016 | |
| NCT03220893 | Active, not recruiting | N/A | Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue | June 14, 2017 | December 31, 2024 |
| NCT05086705 | Active, not recruiting | N/A | EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer | October 7, 2020 | December 31, 2024 |
| NCT05130580 | Active, not recruiting | N/A | Patient-Specific Decision Aid System for Shared Decision Making About Breast Reconstruction | October 13, 2020 | February 2, 2027 |
| NCT03779867 | Active, not recruiting | N/A | Acute Exercise Intervention in Breast Cancer Survivors | March 25, 2019 | December 31, 2024 |
| NCT02874430 | Active, not recruiting | Phase 2 | Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer | June 8, 2016 | June 2023 |
| NCT02876107 | Active, not recruiting | Phase 2 | Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer | October 6, 2016 | October 31, 2025 |
| NCT04257045 | Active, not recruiting | Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives | August 21, 2019 | April 30, 2024 | |
| NCT05364450 | Active, not recruiting | N/A | Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors | July 17, 2021 | August 1, 2024 |
| NCT02408406 | Active, not recruiting | N/A | PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare Providers | July 7, 2015 | June 4, 2024 |
| NCT02436993 | Active, not recruiting | Phase 2 | Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab | April 2015 | June 2024 |
| NCT03650894 | Active, not recruiting | Phase 2 | Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients | April 3, 2019 | April 2025 |
| NCT02465060 | Active, not recruiting | Phase 2 | Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) | August 17, 2015 | December 31, 2025 |
| NCT03612648 | Active, not recruiting | N/A | Three Fraction Accelerated Partial Breast Irradiation as the Sole Method of Radiation Therapy for Low-risk Stage 0 and I Breast Carcinoma | August 30, 2018 | March 22, 2026 |
| NCT04905082 | Active, not recruiting | N/A | HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics | December 30, 2021 | June 30, 2024 |
| NCT03990610 | Active, not recruiting | N/A | An Investigational Surgical Procedure (Vascularized Lymph Node Transfer) in Reducing the Risk of Lymphedema in Patients With Breast Cancer Undergoing Breast Reconstruction | May 24, 2019 | April 30, 2026 |
| NCT01366144 | Active, not recruiting | Phase 1 | Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction | June 20, 2011 | March 5, 2025 |
| NCT04267796 | Active, not recruiting | N/A | Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women | November 22, 2021 | April 30, 2025 |
| NCT02187991 | Active, not recruiting | Phase 2 | Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer | February 12, 2015 | December 2023 |
| NCT03164486 | Active, not recruiting | Early Phase 1 | First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide | November 2016 | December 2024 |
| NCT04989504 | Active, not recruiting | Phase 3 | Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following Mastectomy | July 26, 2022 | December 31, 2025 |
| NCT05224271 | Active, not recruiting | Evaluating Patient Reported Outcomes in Radiation Therapy, The PRO-RT Study | March 2, 2022 | December 30, 2024 | |
| NCT02545023 | Completed | Supportive Care Questionnaires in Gathering Data on Unmet Needs and Health-Related Quality of Life in Latina Breast Cancer Survivors After Surgery, Chemotherapy, or Radiation Therapy | August 10, 2015 | November 26, 2018 | |
| NCT02556632 | Completed | Phase 2 | Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer | October 13, 2015 | September 30, 2016 |
| NCT00115505 | Completed | Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer | October 2005 | June 2016 | |
| NCT00423254 | Completed | Phase 1 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | February 2007 | November 2009 |
| NCT02611544 | Completed | N/A | Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors | December 2015 | December 1, 2016 |
| NCT02632071 | Completed | Phase 1 | ACY-1215 + Nab-paclitaxel in Metastatic Breast Cancer | March 1, 2016 | September 30, 2020 |
| NCT02640053 | Completed | N/A | Topical Cryotherapy in Reducing Pain in Patients With Chemotherapy Induced Peripheral Neuropathy or Paclitaxel Induced Acute Pain Syndrome | December 23, 2015 | October 5, 2018 |
| NCT02827370 | Completed | N/A | CAREFOR: Precision Medicine Driving Precision Nutrition for the Treatment of NeoAdjuvant Breast Cancer | June 16, 2016 | December 15, 2019 |
| NCT05584644 | Completed | A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast Cancer | May 24, 2021 | February 22, 2022 | |
| NCT02870699 | Completed | N/A | Efficacy of Evonail® Solution in the Prevention of Nail Damage Induced by Docetaxel in Patients With Breast Cancer. | October 2011 | June 2016 |
| NCT05583981 | Completed | Stakeholder Assessment of Implementing the Commission on Cancer Operative Standards for Cancer Surgery | December 1, 2021 | June 15, 2022 | |
| NCT05549687 | Completed | N/A | E-Health Support Program (PACK Health Program) in Supporting Patient Reported Symptoms in Newly Diagnosed Patients With Breast Cancer | May 19, 2017 | August 7, 2023 |
| NCT05526872 | Completed | N/A | A Patient Reminder and Self-Referral Via Online Patient Portals and Text Messaging to Improve Adherence to Breast Cancer Screening | September 5, 2022 | June 1, 2024 |
| NCT02961790 | Completed | Phase 3 | Oxybutynin Chloride in Managing Hot Flashes | December 9, 2016 | April 27, 2018 |
| NCT02983279 | Completed | N/A | Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer | September 20, 2016 | December 29, 2022 |
| NCT02997553 | Completed | Phase 3 | Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery | November 29, 2017 | October 12, 2022 |
| NCT03000764 | Completed | N/A | RNA and Heat Shock Protein Biomarkers in Radiation-induced Fibrosis in Breast Cancer | May 10, 2017 | April 25, 2018 |
| NCT03007979 | Completed | Phase 2 | Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer | June 15, 2017 | March 31, 2023 |
| NCT03031561 | Completed | N/A | Ultrasound Imaging Technique in Detecting Breast Microcalcifications in Patients Undergoing Biopsy for a Breast Abnormality | March 1, 2012 | March 10, 2016 |
| NCT03135782 | Completed | N/A | Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy | August 1, 2017 | September 23, 2020 |
| NCT03176979 | Completed | N/A | Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis For Patients With Newly Diagnosed Breast Cancer | April 21, 2017 | July 8, 2021 |
| NCT03180294 | Completed | Phase 2 | Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer | May 31, 2017 | February 22, 2021 |
| NCT05505175 | Completed | Outcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBC | May 30, 2022 | May 2, 2023 | |
| NCT04297384 | Completed | N/A | Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice | February 6, 2019 | August 30, 2022 |
| NCT04456140 | Completed | Phase 1 | Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study | June 29, 2020 | September 21, 2021 |
| NCT04465253 | Completed | N/A | Remotivation Process for Improving Adherence to Lymphedema Treatment Programs in Patients With Breast Cancer-Related Lymphedema | April 19, 2019 | June 21, 2022 |
| NCT00892736 | Completed | Phase 1 | Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy | April 20, 2009 | May 19, 2017 |
| NCT04925817 | Completed | Early Phase 1 | 3D Ultrasound Microvessel Imaging for Breast Masses | August 19, 2021 | May 18, 2023 |
| NCT04902144 | Completed | N/A | Clinical Outcomes for Offering Genetic Testing in a Tiered Approach | August 3, 2020 | December 31, 2021 |
| NCT04693364 | Completed | Acceptability of 3D Printed Breast Models as Surgical Decision Aids for Breast Cancer Treatment | December 27, 2017 | February 22, 2022 | |
| NCT00970983 | Completed | N/A | Axillary Dissection Based on the Histological Result of the Sentinel Node, in Patients With Breast Carcinoma | March 1998 | April 2010 |
| NCT00179348 | Completed | N/A | Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer | February 8, 2001 | July 20, 2016 |
| NCT01091428 | Completed | Phase 2 | Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer | April 16, 2010 | July 19, 2017 |
| NCT04817709 | Completed | Development of a Patient Decision Aid for Women Considering Breast Reconstruction | March 20, 2017 | May 20, 2021 | |
| NCT01139957 | Completed | Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer | June 7, 2010 | April 10, 2020 | |
| NCT06205394 | Completed | Improving The Breast Cancer Care Delivery Model for Sex and Gender Minority Survivors, Intended for SGM Study | August 24, 2022 | October 15, 2023 | |
| NCT01422408 | Completed | Phase 2 | Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy | September 2011 | October 2015 |
| NCT01641068 | Completed | N/A | Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms | September 12, 2012 | January 1, 2018 |
| NCT01671943 | Completed | N/A | Cryotherapy for Breast Cancer Trial | August 2012 | July 2014 |
| NCT01896778 | Completed | N/A | Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer | October 4, 2013 | February 23, 2018 |
| NCT02066532 | Completed | Phase 1/Phase 2 | Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer | June 2014 | October 14, 2020 |
| NCT02192333 | Completed | N/A | Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors | August 3, 2015 | December 31, 2019 |
| NCT02296801 | Completed | Phase 2 | A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer | January 2015 | March 2019 |
| NCT02297412 | Completed | Phase 2 | Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel | November 2014 | July 8, 2016 |
| NCT02352779 | Completed | N/A | Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors | February 2015 | April 2016 |
| NCT02355262 | Completed | CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers | July 1, 2014 | June 30, 2020 | |
| NCT02386371 | Completed | N/A | Intraoperative Radiotherapy After Local Recurrence in Breast Cancer | March 2014 | September 18, 2023 |
| NCT06090630 | Completed | Early Phase 1 | MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer | July 31, 2017 | February 3, 2023 |
| NCT02521961 | Completed | N/A | Support Group Program in Improving Quality of Life in Underserved Urban Latina Breast Cancer Survivors | February 3, 2016 | July 1, 2017 |
| NCT03374995 | Completed | N/A | Topical Keratin in Treating Radiation Dermatitis in Patients With Breast Cancer | March 26, 2018 | November 1, 2018 |
| NCT03517488 | Completed | Phase 1 | A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors | July 10, 2018 | September 6, 2022 |
| NCT03576521 | Completed | Phase 2 | Evaluation of Ocoxin®-Viusid® in Breast Cancer | May 13, 2015 | February 19, 2018 |
| NCT03630354 | Completed | N/A | EXERCISING TOGETHER for Couples Coping With Cancer | January 18, 2019 | January 1, 2024 |
| NCT05161507 | Completed | Magseed and Magtrace Localization for Breast Cancer | May 4, 2020 | December 31, 2023 | |
| NCT03657069 | Completed | N/A | Blossom Smart Expander Technology in Breast Reconstruction in Participants With Breast Cancer Undergoing Mastectomy | August 1, 2018 | August 19, 2020 |
| NCT05158452 | Completed | Development of a Genetic Counseling Patient Preference Intervention for Women at Elevated Risk for Breast Cancer | December 9, 2020 | October 30, 2022 | |
| NCT03831711 | Completed | Phase 1/Phase 2 | 68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer | March 19, 2019 | November 15, 2021 |
| NCT00880503 | Completed | Collection of Tissue Samples for Study of Multidrug Resistance | December 19, 2003 | February 8, 2018 | |
| NCT00887523 | Completed | N/A | Trial Comparing Prone and Supine Intensity-modulated Radiotherapy (IMRT) After Breast-conserving Surgery in Patients With Large Breast Volume at High Risk for Skin Toxicity and Fibrosis | July 2009 | March 8, 2021 |
| NCT03941743 | Completed | Phase 1 | Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast Cancer | December 12, 2019 | November 23, 2021 |
| NCT03964896 | Completed | N/A | Nurse-Driven Telephone Intervention in Improving Side Effects in Cancer Patients Undergoing Chemotherapy | October 17, 2016 | December 18, 2019 |
| NCT05036083 | Completed | N/A | Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion | March 19, 2021 | March 25, 2024 |
| NCT04022772 | Completed | N/A | Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer | July 31, 2019 | July 27, 2023 |
| NCT05021172 | Completed | N/A | Incorporating ePrognosis for the Encouragement of Smarter Screening for Breast and Colorectal Cancer in Older Adults | August 24, 2021 | June 30, 2022 |
| NCT00887692 | Completed | N/A | Comparison of Set-up Reproducibility Between Prone and Supine Intensity Modulated Radiotherapy (IMRT) for the Adjuvant Treatment of Breast Carcinoma After Lumpectomy | July 2009 | October 2010 |
| NCT04208724 | Completed | N/A | Support Program for Adoption of Cancer Screening Interventions at a Rural Community-Based Organization | November 18, 2020 | June 30, 2022 |
| NCT04256512 | Completed | N/A | Cryotherapy for the Prevention of Taxane-Induced Sensory Neuropathy of the Hands and Feet in Breast Cancer Patients | March 10, 2020 | January 18, 2023 |
| NCT03307044 | Completed | N/A | Fractional CO2 Laser Therapy for Survivors of Breast Malignancies | November 16, 2017 | May 5, 2022 |
| NCT03365895 | Completed | N/A | Diffusion Tensor Imaging in Predicting Development of Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer (CIPN) | August 11, 2017 | October 2, 2020 |
| NCT03367572 | Completed | Phase 3 | Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer | April 19, 2018 | February 13, 2024 |
| NCT04081779 | Enrolling by invitation | N/A | Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study | February 19, 2020 | December 31, 2025 |
| NCT05012813 | Enrolling by invitation | N/A | Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer | July 19, 2022 | December 31, 2025 |
| NCT05263362 | Enrolling by invitation | An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study) | April 11, 2022 | September 20, 2025 | |
| NCT05558917 | Enrolling by invitation | N/A | Comparison Between PECS BLOCK 2 vs ESP BLOCK in Ocnologic Breast Surgery | September 7, 2022 | November 7, 2023 |
| NCT06193707 | Not yet recruiting | N/A | Intelligent Remote Intervention for High-risk Breast Cancer Populations | January 2024 | December 2027 |
| NCT06418204 | Not yet recruiting | Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics | August 2024 | August 2028 | |
| NCT04316247 | Not yet recruiting | Demographic , Clinicopathological Characteristics and Survival of Breast Cancer | April 1, 2021 | December 31, 2024 | |
| NCT05941520 | Not yet recruiting | Phase 2 | Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer | October 8, 2024 | September 1, 2028 |
| NCT06422455 | Not yet recruiting | N/A | Access to Genetic Testing in Underserved Patients With Cancer | July 1, 2024 | July 1, 2027 |
| NCT06246084 | Not yet recruiting | N/A | INTENT Pilot Study - Enhancing Adherence Intentions to Endocrine Therapy | July 2024 | December 31, 2024 |
| NCT06336928 | Not yet recruiting | A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis | July 1, 2024 | July 1, 2030 | |
| NCT05178498 | Not yet recruiting | Impact of Dietary Inflammatory Potential on Breast Cancer Risk | September 30, 2023 | December 31, 2025 | |
| NCT05949424 | Not yet recruiting | Phase 4 | OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults | May 2024 | March 2025 |
| NCT06268665 | Not yet recruiting | Phase 2 | Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy | February 28, 2024 | June 2027 |
| NCT06130826 | Not yet recruiting | Phase 1 | Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer | June 12, 2024 | October 22, 2026 |
| NCT05672342 | Not yet recruiting | Early Phase 1 | Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors | July 6, 2024 | October 31, 2025 |
| NCT06195306 | Not yet recruiting | Phase 2 | Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction | June 16, 2024 | January 1, 2027 |
| NCT06184750 | Not yet recruiting | Phase 2 | Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial | November 26, 2024 | July 1, 2028 |
| NCT06456411 | Recruiting | Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With Cancer | July 12, 2022 | July 12, 2026 | |
| NCT00991094 | Recruiting | Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy | May 27, 2005 | December 31, 2025 | |
| NCT02610413 | Recruiting | Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer | March 25, 2014 | January 1, 2100 | |
| NCT02610426 | Recruiting | Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer | March 25, 2014 | January 1, 2100 | |
| NCT02610439 | Recruiting | Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer | March 25, 2014 | January 1, 2100 | |
| NCT03408353 | Recruiting | Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study | September 15, 2017 | April 30, 2025 | |
| NCT03604315 | Recruiting | Phase 1 | Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF | December 18, 2018 | June 30, 2027 |
| NCT03870620 | Recruiting | Metastatic Breast Cancer in Austria | June 15, 2015 | June 2025 | |
| NCT03897270 | Recruiting | N/A | Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects | October 25, 2018 | May 31, 2025 |
| NCT04147494 | Recruiting | Early Phase 1 | Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues | November 5, 2019 | October 17, 2031 |
| NCT04475640 | Recruiting | N/A | Cancer Genetic Testing in Ethnic Populations | December 13, 2019 | October 15, 2024 |
| NCT04562623 | Recruiting | Prospective Study of Immune Alterations in Operable Breast and Ovarian Carcinoma | July 1, 2021 | July 2031 | |
| NCT04711109 | Recruiting | Phase 3 | Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation | February 14, 2023 | December 2033 |
| NCT04721886 | Recruiting | Early Phase 1 | Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer | November 24, 2020 | January 1, 2025 |
| NCT04794816 | Recruiting | What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven Care | January 21, 2021 | October 31, 2025 | |
| NCT04799535 | Recruiting | Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring | September 1, 2019 | November 29, 2028 | |
| NCT04849871 | Recruiting | N/A | Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma | August 12, 2021 | June 30, 2029 |
| NCT04852926 | Recruiting | Study of the Sexual Health of Patients Treated for Breast Cancer and Followed up in the Observatory of Fertility at Jeanne de Flandre Hospital. | July 13, 2021 | July 2025 | |
| NCT04862585 | Recruiting | Phase 2/Phase 3 | Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel | October 7, 2021 | December 31, 2024 |
| NCT04871139 | Recruiting | N/A | An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer | April 8, 2021 | March 1, 2026 |
| NCT04913064 | Recruiting | N/A | Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer | July 27, 2021 | July 12, 2024 |
| NCT04993313 | Recruiting | N/A | Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study | March 18, 2022 | February 28, 2025 |
| NCT04996316 | Recruiting | MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals | September 7, 2022 | August 31, 2025 | |
| NCT05045287 | Recruiting | N/A | Hypofractionated Post Mastectomy Radiation With Two-Stage Expander/Implant Reconstruction | April 8, 2021 | April 30, 2025 |
| NCT05046301 | Recruiting | Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications | March 23, 2021 | February 2, 2027 | |
| NCT05056818 | Recruiting | Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics | December 15, 2020 | October 31, 2026 | |
| NCT05056844 | Recruiting | N/A | Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge | April 15, 2021 | April 30, 2024 |
| NCT05056857 | Recruiting | Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen | October 1, 2021 | October 31, 2024 | |
| NCT05132296 | Recruiting | N/A | Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer | May 21, 2021 | February 2, 2027 |
| NCT05150652 | Recruiting | Phase 2 | Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer | February 18, 2022 | October 2036 |
| NCT05226663 | Recruiting | Phase 2 | A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer | February 27, 2023 | August 20, 2026 |
| NCT05252390 | Recruiting | Phase 1/Phase 2 | NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors | March 29, 2022 | November 2026 |
| NCT05325151 | Recruiting | N/A | Genetic Counseling Patient Preference Intervention Versus Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer | June 13, 2022 | October 31, 2025 |
| NCT05372640 | Recruiting | Phase 1 | Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors | August 10, 2023 | June 1, 2025 |
| NCT05406232 | Recruiting | Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer | September 15, 2023 | December 31, 2026 | |
| NCT05507879 | Recruiting | TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer | August 18, 2022 | September 1, 2027 | |
| NCT05544123 | Recruiting | The Treatment Situation of Chinese County Population With Breast Cancer | September 29, 2022 | September 2024 | |
| NCT05557877 | Recruiting | Phase 2 | Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer | February 14, 2023 | January 30, 2027 |
| NCT05612100 | Recruiting | Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients | December 12, 2022 | August 1, 2024 | |
| NCT05700396 | Recruiting | N/A | Breast Cancer Survivor Educational Intervention | February 28, 2023 | December 31, 2023 |
| NCT05703269 | Recruiting | N/A | Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy | July 11, 2023 | March 31, 2028 |
| NCT05703399 | Recruiting | Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study | January 27, 2023 | December 31, 2033 | |
| NCT05704283 | Recruiting | Early Phase 1 | 3D Ultrasound for the Imaging of Axillary Lymph Nodes in Patients With Breast Cancer | February 14, 2023 | April 1, 2025 |
| NCT05716893 | Recruiting | Phase 2 | Study of Aerobic Training for People Receiving Chemotherapy for Breast Cancer | January 30, 2023 | January 30, 2028 |
| NCT05747794 | Recruiting | Phase 2/Phase 3 | Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination With Paclitaxel Chemotherapy | May 22, 2023 | July 31, 2027 |
| NCT05755269 | Recruiting | Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women | March 14, 2023 | January 15, 2033 | |
| NCT05787834 | Recruiting | N/A | Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer | October 16, 2023 | October 16, 2029 |
| NCT05978128 | Recruiting | N/A | Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants | July 28, 2023 | September 30, 2029 |
| NCT06036875 | Recruiting | CARE: Cancer Risk Perception and Women of Color | February 23, 2023 | February 23, 2028 | |
| NCT06049355 | Recruiting | Phase 2 | EMBRACE: Exercising Together | April 18, 2024 | September 1, 2028 |
| NCT06055881 | Recruiting | Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy (BOSS) | October 23, 2023 | October 30, 2025 | |
| NCT06060561 | Recruiting | Genetic Testing to Improve Management of Patients Undergoing Breast Biopsy | May 30, 2023 | June 30, 2028 | |
| NCT06112613 | Recruiting | N/A | Mobile Health for Adherence in Breast Cancer Patients | January 26, 2024 | July 31, 2027 |
| NCT06112795 | Recruiting | Exploring Cultural Acceptability of Community Breast Cancer Risk Assessment Among Hispanic Women in Maricopa County | October 5, 2022 | March 1, 2026 | |
| NCT06125314 | Recruiting | HER2 TREAT Study: Retrospective Study to Estimate the Prevalence of HER2-low in Unresectable and/or Metastatic Breast Cancer Patients Who Progress on Anti-Cancer Therapy Identified as HER2-Negative From Patient Medical Records in The Gulf Cooperation Council | March 5, 2024 | December 31, 2024 | |
| NCT06144164 | Recruiting | Phase 3 | A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer | November 16, 2023 | March 16, 2030 |
| NCT06171607 | Recruiting | Phase 1 | Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses | November 5, 2020 | November 5, 2025 |
| NCT06195709 | Recruiting | Phase 3 | ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients | April 17, 2024 | August 15, 2029 |
| NCT06202118 | Recruiting | N/A | A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients. | February 19, 2024 | June 2026 |
| NCT06217874 | Recruiting | Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer | June 5, 2014 | June 30, 2034 | |
| NCT06219434 | Recruiting | N/A | Evaluation of a Mindfulness Intervention to Prevent Chemo-brain in Women Preparing for Chemotherapy for Breast Cancer | November 13, 2023 | October 1, 2024 |
| NCT06274034 | Recruiting | Early Phase 1 | MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors | January 8, 2024 | January 31, 2025 |
| NCT06285747 | Recruiting | A Correlational Study: Breast Cancer-related Chest Wall Lymphedema, Quality of Life, and Shoulder Function | July 28, 2023 | August 1, 2025 | |
| NCT06335108 | Recruiting | Postoperative Pain After Breast Surgery Under Tumescent Local Anaesthesia Versus General Anaesthesia ( TLA-001 ) | December 5, 2022 | December 1, 2024 | |
| NCT06350500 | Recruiting | N/A | A Patient Navigation Program for Addressing Disparities in Breast Cancer Care | June 15, 2024 | January 1, 2026 |
| NCT06439940 | Recruiting | Oncoliq: Early Breast Cancer Detection Based on Liquid Biopsies and microRNAs | July 14, 2021 | March 31, 2025 | |
| NCT04955808 | Suspended | Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery | February 7, 2017 | December 31, 2026 | |
| NCT01569321 | Terminated | N/A | Diagosis of Breast Carcinoma: Characterization of Breast Lesions With CLEARPEMSONIC : Feasibility Study | March 2012 | March 2013 |
| NCT02810873 | Terminated | N/A | Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer | September 2008 | July 2012 |
| NCT02483377 | Terminated | Patient Navigation and Tailored Treatment Planning in Latina Patients With Breast Cancer | March 5, 2015 | February 7, 2017 | |
| NCT03957096 | Terminated | Phase 1 | A Safety Study of SGN-CD47M in Patients With Solid Tumors | July 17, 2019 | September 14, 2020 |
| NCT02708511 | Terminated | Phase 1 | Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer | August 2016 | October 11, 2017 |
| NCT03609021 | Terminated | Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502 | August 1, 2018 | July 18, 2022 | |
| NCT02890368 | Terminated | Phase 1 | Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides | September 2016 | March 31, 2020 |
| NCT03630601 | Terminated | N/A | Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy Volunteers | June 28, 2018 | March 15, 2023 |
| NCT02907918 | Terminated | Phase 2 | Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer | June 30, 2017 | September 23, 2020 |
| NCT00183963 | Terminated | Phase 2 | A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS) | August 2006 | June 2008 |
| NCT03970967 | Terminated | N/A | Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases | August 28, 2019 | November 30, 2023 |
| NCT02923037 | Terminated | N/A | Hatha Yoga in Breast Cancer Survivors | September 1, 2016 | March 2019 |
| NCT00520975 | Terminated | Phase 3 | Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU | November 2007 | October 2015 |
| NCT04541225 | Terminated | Phase 1 | Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors | December 8, 2020 | August 31, 2022 |
| NCT00770354 | Terminated | Phase 2 | Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer | September 2008 | August 2011 |
| NCT05133674 | Unknown status | Phase 2 | Therapeutic Dose Monitoring (TDM) of Tamoxifen | April 4, 2022 | March 1, 2023 |
| NCT04688697 | Unknown status | N/A | Prepectoral and Subpectoral Implant-based Breast Reconstruction | January 1, 2021 | November 30, 2022 |
| NCT04671498 | Unknown status | Droplet-BC Screening Test for the Detection of Breast Cancer, the DROPLET-BC Study | November 3, 2020 | December 31, 2022 | |
| NCT02441972 | Unknown status | Phase 1 | Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics | January 2012 | December 2020 |
| NCT04262518 | Unknown status | N/A | Feasibility of Integrating the Outcomes4Me Smartphone Navigation Application Into the Care Management of Breast Cancer Patients | June 1, 2020 | October 2020 |
| NCT01400399 | Unknown status | Cosmetic Evaluation of Lumpectomy Versus Oncolytic Mammoplasty With Bilateral Breast Reduction for Early Stage Breast Cancer | August 2010 | August 2020 | |
| NCT01655004 | Unknown status | N/A | Prospective Study of UDP-gluconoryltransferase 2B17 Genotype as a Predictive Marker of Exemestane PK and PD | August 2012 | August 2018 |
| NCT01199354 | Unknown status | Phase 2 | Skin Sparing Mastectomy and Immediate Breast Reconstruction With Latissimus Dorsi Flap After Neoadjuvant Chemotherapy and Radiotherapy (M-RIC) | July 2010 | July 2017 |
| NCT02858856 | Unknown status | N/A | Clinical Trial of Sipjeondaebo-tang on Fatigue of Breast Cancer Patients | March 20, 2017 | June 2018 |
| NCT05150535 | Unknown status | N/A | One Week Adjuvant Radiotherapy for Breast Cancer | October 1, 2021 | October 1, 2023 |
| NCT05151224 | Unknown status | Circulating microRNA 21 Expression Level Before and After Neoadjuvant Systemic Therapy in Breast Carcinoma | December 2021 | January 2024 | |
| NCT03710018 | Unknown status | Impact of Tumor Bed Localisation on Dosimetry Boost Irradiation in Patients Undergoing Breast Conserving Surgery | July 1, 2017 | June 30, 2019 | |
| NCT01462903 | Unknown status | Phase 1 | A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors | September 2011 | December 2014 |
| NCT02898376 | Unknown status | Phase 3 | Clinical Benefit of Spa Care on Severe Radiation-induced Fibrosis After Postoperative Radiotherapy for Breast Cancer | December 2018 | December 2021 |
| NCT05191004 | Withdrawn | Phase 1/Phase 2 | Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC | September 2022 | September 2026 |
| NCT03563352 | Withdrawn | Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer | August 30, 2018 | September 24, 2020 | |
| NCT00899145 | Withdrawn | Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers | May 2008 | ||
| NCT03804255 | Withdrawn | Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting | January 8, 2019 | May 29, 2020 | |
| NCT03408561 | Withdrawn | N/A | Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer | November 8, 2017 | December 31, 2018 |
| NCT05073172 | Withdrawn | N/A | StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients | January 1, 2024 | July 1, 2025 |
| NCT03185871 | Withdrawn | Phase 2 | Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses | September 20, 2017 | October 10, 2018 |
| NCT01640847 | Withdrawn | Phase 2 | MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases | July 2012 | July 2013 |
| NCT06137651 | Withdrawn | Phase 1 | Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis | December 31, 2023 | March 27, 2024 |
| NCT03110445 | Withdrawn | Phase 1 | Cancer/Testis Antigen Immunotherapy Phase I Study With 740-CTA Vaccinia Virus | March 2020 | September 2021 |
| NCT05005936 | Withdrawn | Comparing the Performance of Automated Breast Ultrasonography to Hand-Held Whole Breast Ultrasonography in Breast Cancer Treatment Response Assessment | November 29, 2021 | November 29, 2021 | |
| NCT05041751 | Withdrawn | N/A | Myofascial Release or Trigger Point Injections for the Reduction of Post-Mastectomy Pain Syndrome | March 23, 2022 | March 23, 2022 |
| NCT04054752 | Withdrawn | Phase 1 | Vaccine Response With NT-I7 | May 30, 2023 | November 1, 2023 |
| NCT04190433 | Withdrawn | Phase 2 | Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial | September 1, 2020 | April 18, 2023 |
| NCT00712621 | Withdrawn | Phase 2 | Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or Combination | February 2010 | February 2014 |
| NCT05774886 | Withdrawn | Phase 1 | Implantable Microdevice for TNBC - Pilot Study | May 2023 | September 1, 2028 |
| NCT06145399 | Withdrawn | Early Phase 1 | A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer | October 24, 2023 | April 29, 2024 |
- Disase is a (Disease Ontology)
- DOID:1612
- Cross Reference ID (Disease Ontology)
- EFO:0000305
- Cross Reference ID (Disease Ontology)
- MESH:D001943
- Cross Reference ID (Disease Ontology)
- NCI:C4872
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:154513000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0678222
- Exact Synonym (Disease Ontology)
- carcinoma of breast
- Exact Synonym (Disease Ontology)
- Mammary carcinoma
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0003002